
Dr. Amy Degnim, a Mayo Clinic surgeon, says breast cancer is not one-size-fits-all, and treatments depend on many factors.
“Breast cancer is an entire spectrum of disease, from very-low grade ductal carcinoma in situ, which is almost similar to just an atypical finding that is considered benign, all the way up to the other end of the spectrum, which is a very high-grade, invasive tumor,” says Dr. Degnim.
Treatment depends on several factors, including what the cancer looks like under a microscope.
“Some tumors have strong estrogen receptors on the outside of their tumor cells, and some tumors do not. Some tumors have HER2 receptors,” says Dr. Degnim.
Cell receptors determine treatment options, which can be targeted to specific types of tumors.
“So in terms of creating treatment plans, it is quite complex. We recommend that that be done often through a multidisciplinary team,” says Dr. Degnim.
Treatment plans may include surgery, chemotherapy, radiation and medication depending on type, size, stage, location and grade of tumor.
The encouraging news is that treatment for breast cancer keeps getting better.
“We have come a long way in the last few decades,” says Dr. Degnum. She goes on to say that most women survive breast cancer.
‘Courtesy: Mayo Clinic News Network.’[/vc_message]
Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components